abiraterone acetate, Janssen Biotech, MAGNITUDE, mCRPC, Niraparib
Niraparib uye abiraterone acetate plus prednisone inotenderwa neFDA yeBRCA-mutated metastatic castration-resistant cancer cancer
Nyamavhuvhu 2023: Iyo yakatarwa dosi musanganiswa weniraparib uye abiraterone acetate (Akeega, Janssen Biotech, Inc.), pamwe neprednisone, yakabvumidzwa neFood and Drug Administration yevarwere vakuru vane castration-resista.
Janssen Biotech, MonumentAL-1, akawanda myeloma, Talquetamab-tgvs, Talvey
Talquetamab-tgvs yakagamuchira kukurumidza kubvumidzwa kwekudzoreredza kana kuramba akawanda myeloma.
Nyamavhuvhu 2023: Talquetamab-tgvs (Talvey, Janssen Biotech, Inc.) yakapihwa mvumo yekukurumidzira neFood and Drug Administration yekurapwa kwevakuru vane kudzokazve kana kuramba akawanda myeloma avo vakamboitika pa.
Janssen Biotech, MajesTEC-1, NCT03145181, teclistamab-cqyv, Tecvayli
Teclistamab-cqyv inotenderwa neFDA kudzoreredza kana kuramba akawanda myeloma.
Mbudzi 2022: Yekutanga bispecific B-cell maturation antigen (BCMA) -yakanangidzirwa CD3 T-cell engager, teclistamab-cqyv (Tecvayli, Janssen Biotech, Inc.), yakapihwa kukurumidza kubvumidzwa neFood and Drug Administration yevakuru pat.
CAR-T kurapwa, chimeric antigen receptors, China, ciltacabtagene autoleucel, Janssen Biotech, Legend biotech
CARVYKTI (ciltacabtagene autoleucel), BCMA-Yakanangana neCAR-T Therapy, inogamuchira US FDA mvumo yekurapa varwere vakura vane kudzokazve kana kuti refractory multiple myeloma.
Kurume 2022: Sekureva kwaJohnson & Johnson, mushonga wakagadzirwa nekambani pamwe newayo wekuChina weLegend Biotech Corp kurapa rudzi rwegomarara reropa rakabvumidzwa neUS Food and Drug Administrati.
BCMA, CARVYKTI, ciltacabtagene autoleucel, immunomodulatory mumiririri, Janssen Biotech, proteasome inhibitor
Ciltacabtagene autoleucel inotenderwa kudzokororwa kana refractory akawanda myeloma
Kurume 2022: Mushure memitsara mina kana kupfuura yekutanga yekurapa, kusanganisira proteasome inhibitor (PI), immunomodulatory agent (IMiD), uye anti-CD38 monoclonal antibody, iyo Food and Drug Administration yakabvumidza ciltacabtagene kana.
Amgen, carfilzomib, Darzalex Faspro, dexamethasone, Janssen Biotech, Kyprolis, akawanda myeloma
Darzalex faspro, kyprolis, uye dexamethasone inotenderwa neFDA kune akawanda myeloma.
Kurume 2022: Daratumumab + hyaluronidase-fihj (Darzalex Faspro, Janssen Biotech, Inc.) uye carfilzomib (Kyprolis, Amgen, Inc.) pamwe nedexamethasone zvakatenderwa neChikafu neDrug Administration kuvarwere vakuru vane relap.
Daratumumab, Darzalex Faspro, dexamethasone, Hyaluronidase-fihj, Janssen Biotech, pomalidomide
Daratumumab uye hyaluronidase-fihj pamwe pomalidomide uye dexamethasone zvakagamuchirwa neDFA yekurapa kwakawanda myeloma
Nyamavhuvhu 2021: Daratumumab uye hyaluronidase-fihj (Darzalex Faspro, Janssen Biotech, Inc.) zvakagamuchirwa neKudya neDrug Administration pamwe ne pomalidomide uye dexamethasone yevakuru varwere vane akawanda angu ..